MedPath

Viral Triggers in Pediatric Lung Transplantation

Completed
Conditions
Lung Transplant
Obliterative Bronchiolitis
Bronchiolitis Obliterans
Registration Number
NCT00891865
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to determine whether respiratory viral infections increase the risk of bronchiolitis obliterans syndrome (BOS), obliterative bronchiolitis (OB), death, or retransplantation in children who have received lung transplants.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
61
Inclusion Criteria
  • Parent or legal guardian willing and able to provide informed consent
  • Participant of first single or bilateral heart-lung transplant
Exclusion Criteria
  • Recipient of multi-organ transplant (aside from heart-lung)
  • Condition or characteristic which in the opinion of the investigator makes the participant unlikely to complete the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The earliest time to BOS or OB, retransplantation or deathWithin 24 months of transplant
Secondary Outcome Measures
NameTimeMethod
Time to each of the following events: BOS or OB, retransplantation or deathWithin 24 months of transplant

Trial Locations

Locations (6)

Stanford University

🇺🇸

Palo Alto, California, United States

Nationwide Children's Hospital

🇺🇸

Columbus, Ohio, United States

Texas Children's Hospital

🇺🇸

Houston, Texas, United States

Children's Hospital Boston

🇺🇸

Boston, Massachusetts, United States

Washington University

🇺🇸

Saint Louis, Missouri, United States

Children's Hospital of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath